Human brucellosis: Review of an under-diagnosed animal transmitted disease

Journal of Communicable Diseases

Volumn 34, Issue 4, 2002, Pages 287-301

  Thakur, S D ^a   Kumar, R ^a   Thapliyal, D C ^a  

^a G B PANT UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; DOXYCYCLINE; GENTAMICIN; OFLOXACIN; RIFAMPICIN; STREPTOMYCIN; TETRACYCLINE DERIVATIVE; ANTIINFECTIVE AGENT;

BACTERIAL ENDOCARDITIS; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; BACTERIUM ISOLATE; BRUCELLA; BRUCELLOSIS; CHRONIC DISEASE; CLINICAL FEATURE; DEVELOPING COUNTRY; DIAGNOSTIC ERROR; DIAGNOSTIC TEST; DISEASE TRANSMISSION; FILARIASIS; FOOD; HEALTH CARE MANAGEMENT; HISTORY OF MEDICINE; HUMAN; INFECTION; INFECTION CONTROL; INFECTION PREVENTION; ISOLATION PROCEDURE; LEISHMANIASIS; LEUKEMIA; LIVER CIRRHOSIS; MENINGITIS; NONHUMAN; PATIENT; PHYSICIAN; PREVALENCE; PYREXIA IDIOPATHICA; RECORDING; REVIEW; RHEUMATOID ARTHRITIS; SCIENCE; SCREENING; SENSITIVITY AND SPECIFICITY; SEROLOGY; SYMPTOM; TREATMENT INDICATION; TUBERCULOSIS; TYPHOID FEVER; UROGENITAL TRACT INFECTION; ANIMAL; CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; PATHOGENICITY; PATHOPHYSIOLOGY;

ANIMALS; ANTI-BACTERIAL AGENTS; BRUCELLA; BRUCELLOSIS; DIAGNOSTIC ERRORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; PREVALENCE;

EID: 1242309835     PISSN: 00195138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (94)

1. W.H.O. The development of new improved brucellosis vaccine. Joint FAO/WHO expert committee. 1997; WHO/EMC/ZD1/98.14.
2. Schwabe CW. Human health costs of animal disease In: Veterinary medicine and human health. 1984; pp. 35.
3. Patel et al. Serological evidence of brucellosis in human beings in Kaira district of Gujarat. Ind J Pub Hlth 1986; 30: 197-200.
4. Retmal P, Blenk O, Abalos P and Torres D. Detection of anti Brucella antibodies in pinnipeds from Antarctic territory. Vet Rec 2000; 146: 166-168.
5. Shehu LM, Elutade F and Kudi AC. Serological survey of brucellosis in chickens, guinea fowls, ducks and turkey in Bauchi and Environs. Nigerian Vet J 1999; 20: 47.
6. Bruce D. Note on the discovery of a microorganism in Malta Fever. Practitioner 1887; 39: 161-170.
7. Wright AE and Smith F. On the application of the serum test to the differential diagnosis of typhoid and Malta fever. Lancet 1897; 1: 656.
8. Zammit T. Report of the Commission on Mediterranean Fever, part III, Harrison. and Sons, London 1905; pp. 83.
9. Meyer KF and Shaw EB. Comparison of morphologic, cultural and biochemical characteristics of Brucella abortus and Brucella melitensis. Studies on genus Brucella Nov. Gen. 1. J Infect Dis 1920; 27: 173-184.
10. Thapliyal DC. Brucellosis. In: Diseases of animals transmissible to man. (1999). pp. 111.
11. W.H.O. Global estimation for health situation assessment and projection. World Health Organization 1990; WHO/HST/90.2.
12. Elberg SS. A guide to the diagnosis, treatment and prevention of human brucellosis. World Health Organization. 1981; VPH/81. 31 Rev.
13. Meyer ME. Species identity and epidemiology of Brucella strains isolated from Alaskan Eskimos. J Infect Dis 1964; 114: 169-173.
14. Ferguson MAD. Rangiferine brucellosis on Baffin Island. J Wildlife Dis 1997; 33: 536.
15. Report. La Rage et al. Brucellose dans Ie Bassin Mediterranian et al peninsule arabe, 1986; Collection Foundation Marcel Merieux, Lyon.
16. Lopez-Merino, A. In: Brucellosis Clinical and Laboratory Aspect. 1989; pp. 151.
17. Report. Human and bovine brucellosis in Britain. Br Med J 1980; 1: 1458.
18. Sharma RK. Seroepidemiology of brucellosis of in man and animals. M.V.Sc. thesis submitted to G.B. Pant University of Agriculture and Technology, Pantnagar. 2000.
19. Mantur BG. and Mangalgi SS. In: Proceedings of Indian Veterinary Congress, IVRI, Izatnagar, 18-19 Feb. 2000.
20. Taylor JP and Perdue JN. The changing epidemiology of human brucellosis in Texas, 1977-1986. Am J Epidemiol 1989; 138: 160-165.
21. Thakur SD. Sero-epidemiology of animal and human brucellosis. M.V.Sc. thesis submitted to G.B. Pant University of Agriculture and Technology, Pantnagar. 2002.
22. Mathur TN. Brucellosis in Haryana In: National Seminar on zoonosis in India. 1968; 9-16 Oct. Delhi.
23. Sehgal S and Bhatia R. Zoonoses in India. J Commun Dis 1990; 22: 227.
24. Mathur TN. Brucella strains isolated from cows, buffaloes, goats, sheep and human beings at Karnal. Their significance with regard to the epidemiology of brucellosis. Ind J Med Res 1964; 52: 1231.
25. Panjarathinam R and Gulrajani TS. Incidence of brucellosis in man and animal. Ind Vet 1973; J 50: 103.
26. Randhawa AS, Kalra DS and Kapur MP. Some sero-epidemiological observations on brucellosis in humans and animals. Ind J Med Sci 1974; 28: 133.
27. Thapliyal DC. Animal brucellosis and human infection. Sheep, goats and pigs as reservoirs of Brucellosis infection for man. In: National Seminar on Zoonosis in India. 1968. Delhi.
28. Sethi MS and Singh VB. Final Technical Report P.L.480. G. B. Pant University of Agriculture and Technology, Pantnagar. 1980; 19-25 pp.
29. Maansi. Sero-epidemiology of brucellosis in animal and man in Tarai region. M.V. Sc. thesis submitted to G.B. Pant University of Agriculture and Technology, Pantnagar. 1999.
30. Panjarathinam R and Jhala CI. Bffirucellosis in Gujarat state. J Pathol Microbiol 1986; 29: 53-60.
31. Mangalgi SS, Mantur BG, Shrikant B and Peerapur BV. Human brucellosis: An experience of eleven years study. In: Proceeding of Indian Veterinary Congress. IVRI, Izatnagar, 18-19 Feb. 2000.
32. Chauhan RS. Brucellosis in India and its impact on export of buffalo meat. Ind J Ani Prod 1999; 31: 316-317.
33. Mohanty TN, Panda SN, Das BR, Pardhan SK and Pradhan RK. Sero incidence of brucellosis among dairy farm workers in Orissa. Ind Vet J 2000; 77: 568.
34. Barbuddhae SB, Kumar P, Malik SVS, Singh DK and Gupta LK. J Comm Dis 2000; 32: 295-299.
35. Buchanan TM and Sulzer CR. Brucellosis in the United States 1960-1972. An abbatoir -associated disease. Part II. Diagnosis aspects. Medicine (Baltimore). 1974; 53: 667-689.
36. W.H.O. Sixth Report. World Health Organization, Technical Report Series 1986. 740.
37. Gossens H and Marcelis L. Brucella melitensis. Person to person transmission? Lancet 1986; 1: 773.
38. Mantur BG, Mangalgi SS and Mulimani M. Brucella melitensis - a sexually transmissible agent. Lancet 1996; 347: 1763.
39. Naparstek E, Block CS and Salvin S. Transmission of brucellosis by bone marrow transplantation. Lancet 1982; 1: 574.
40. Paton NI, Teu NWS, Vu CFK and Teo TP. Brucellosis due to blood transfusion. Clio Infect Dis 2001; 32: 1248.
41. Varon E, Chohen R, Bouhanna CA, Canet J, Janaud JC and Gestlin P. Brucellosis in a 3 month old infant. Arch. Francaisesde Pediatrie 1990; 47: 8.
42. Al Mofada SM, Al Eissa YA, Saeed ES and Kambal AM. Isolation of Brucella melitensis from human milk. J Infect 1993; 26: 346-348
43. Rasch G, Schoenberg I, Apitzsch L and Menzel U. Brucellosis in Gennany. Bundesgesundheitsblatt 1997; 40: 50-51, 53-54.
44. Wallach JC, Miguel SE, Baldi PC, Guanera E, Goldbaum FA and Fossati CA. Urban outbreak of a Brucella melitensis infection in an Argentine family: clinical and diagnostic aspects. FEMS immunology and Medical Microbiology 1994; 8: 49-56.
45. Eckman MR. Brucellosis linked to the French cheese. J Am Med Assoc 1975; 232: 636-637.
46. Botehlo AP, Mota RA, Silva LBGda, Santos Filho FS, Coelho RM, Lima ET de;da Silva LBG and de Lima ET. Recovery of Brucella abortus from raw milk from seropositive cows in Pedra and Venturosa, Pernambuco [Brazil]. Public Health aspects. Higiene Alimentar 2000; 14: 72.
47. Bortus IH and Harris DM. A milk borne epidemic of brucellosis. J Am Med Assoc 1943; 121: 319-322.
48. Dalrymple-Champnpeys, W. Brucella Infection and Undulant Fever in Man. 1960. Oxford University Press, London.
49. Report Joint FAD/WHO expert committee on Brucellosis, 1971; 6th report. WHO technical report series no. 464.
50. Pike RM. Past and present hazards of working with infectious agents. Arch Path Lab Med 1978; 102: 333-336.
51. Collins CH. Laboratory acquired infections. 1983. Butterworths, London.
52. Brew SD, Peorrett LL, Stack JA, MacMillan AP and Staunton NJ. Vet Rec 1999; 144: 483.
53. Sadusk JF, Browne AS and Brone JL. Brucellosis in man resulting from Brucella abortus (Strain 19) vaccine. J Am Med Assoc 1957; 164: 1325-7.
54. Olle Goig JE and Camela-Soler J. An outbreak of Brucella melitensis infection by air borne transmission among laboratory animals. Am J Pub Hlth 1987; 77: 335-8.
55. Young EJ and Corbel MJ. Brucellosis: Clinical and Laboratory Aspect. 1989.
56. Young, E.J. Human brucellosis. Rev Infect Dis 1983; 5: 821-842.
57. Dognany M, Aygen B and Esel D. Visceral abcesses due to Brucella suis infection in a retired pig fanner. J Hosp Infect 2001; 49: 151-152
58. Hodinka L and Gomor B. HLA-B27-associated spondloarthritis in chronic brucellosis. Lancet 1978; 1: 499
59. Young EJ. Serological diagnosis of human brucellosis: analysis of 214 cases by agglutination tests and review of literature. Rev Infect Dis 1991; 13: 359-372.
60. Labani M, Sharda D and Helin I Cardiac manifestations in brucellosis. Arch Dis Child 1986; 61: 569-572.
61. Shakir RA. Neurobrucellosis. Postgrad Med J 1986; 62: 1077.
62. Katti MK, Sarada C, Sivasankaran S and Shanmugnam J. Serological diagnosis of human brucellosis: analysis of seven cases with neurological and cardiological manifestations. J Comm Dis 2001; 33: 36-43.
63. Asian D, Korkmaz ME, Kart H and Gaul C. Management of Brucella endocaditis of a prosthetic valve. J Infect 1998; 37: 70-71.
64. Buchanan WW and Kean WF. Robert Bum's illness resisted. Scottish Med J 1982; 27: 75-88.
65. Williams E. Brucellosis. Br Med J 1973; 1: 791
66. Gotuzzo E and Carillo C. An evaluation of diagnostic methods for brucellosis-the value of bone culture. J Infect Dis 1986; 153: 122-125.
67. Gilbert R and Dacey HG. The isolation of an organism of the abortus-melitensis group from the blood clot, the senun of which failed to give agglutination with B. abortus. J Lab Clio Med 1932; 17: 345-346.
68. Hellmann E. Brucella melitensis. In: Handbuch der Bakteriellen Infektionen bei Tieren 1982; pp, 214-260.
69. Wilkinson, P.G. Immunoglobulin patterns of anibodies against Brucella in man. J Immunol 1966; 96: 457-467.
70. Serre A, Dana M and Roux J. Nature des anticorps bloquants dans la brucellose humaine. Pathol Biol 1970; 18: 367-374.
71. Diaz R, Maravi-Poma E and Rivero A. Comparison of counter- immunoelectrophoresis with other serological tests in the diagnosis of human brucellosis. Bull WHO 1976; 53: 417-424.
72. Diaz R and Maravi-Poma E. Rose Bengal plate agglutination and counter immunoelectophoresis test on spinal fluid in the diagnosis of Brucella meningitis. J Cli Microbiol 1978; 7: 236-237.
73. Laudat P, Van DerMee-Marquet N, Loulergue J and Audurier A. Informative capacity of 8 serological tests in the diagnosis of human brucellosis. Pathol Biol 1995; 43: 754.
74. Matar GM, Khnessie IA and Abdelnoor AMN. Rapid laboratory conformation of human brucellosisi by PCR analysis of target sequence of 31-kilodalton Brucella antigen DNA. J Clin Microbiol 1996; 34: 477.
75. Tang LY, Qiu RY and Li YK. The epidemiologic value of polymerase chain reaction to the diagnosis of brucellosis patients. Zhonghua Liu Xing BingXue Za Zhi 1997; 18: 153.
76. Al-Nakkas AF, Wright SG, Mustafa AS and Wilson S. Single tube nested PCR for the diagnosis of human brucellosis in Kuwait. Ann Trop Med Parasitol 2002; 96: 397.
77. Morata P, Queipo-Ortuno MI, Reguera JM, Garcia-Ordonez MA, Cardenas A and Colmenero JD. Development and evaluation of a PCR-enzyme linked immunosorbent assay for diagnosis of human brucellosis. J Clin Microbiol 2003; 41: 144.
78. Serre A. Immunology and pathophysiology of human brucellosis. In: Brucellosis: Clinical and Laboratory Aspects. 1989; pp 85-95.
79. Alton GG, Jones LM and Pietz DE. Laboratory Techniques in Brucellosis. 1975; 2nd Edition Monograph series no. No. 55, WHO, Geneva.
80. Plommet M. In: 2nd Forum in Microbiology. Ann Inst Pastaur Microbiol 1987; pp, 69. Paris.
81. WHO. Laboratory Biosafety Mannual. 1983; World Health Organization. Geneva.
82. Franz DR, Jahrling PB, Friedlander AM, McClain DJ, Hoover DL, Bryne WR, Pavlin JA, Christopher GW and Eitzen EM. Jr Clinical recognition and management of patients exposed to biological warfare agents. Am Med Aossoc 1997; 278: 399-411.
83. Vershilovia PA. The use of live vaccine for vaccination of human beings against brucellosis in the USSR. Bull WHO 1961; 24: 85-89.
84. Lopez Merino A, Asselineau J, Serre A, Roux J, Bascoul S and Lacave C. Immunization by an insoluble fraction extracted from Brucella melitensis: immunological and chemical characterization of the active substances. Infect Immun 1976; 13: 311.76.
85. Bentejac MC, Biron G. et al. Vaccination cotre la brucellose humaine. Bialn sur une periode de 4 ans. Dev Biol Stand 1984; 56: 531.
86. Dranovskaya EA. New approaches to brucellosis vaccination of people with high risk of infection. In: Brucella and brucellosis in man and animals. Tumbay E, Hilmi S. Ang O. eds. Ege University Press. Izmir Turkish Microbiology Society 1991; 16: 87.
87. Jacques I, Olivier BY and Dubray G. Induction of antibody and protective response in mice by Brucella O-polysaccharide-BSA conjugate. Vaccine 1991; 9: 896.
88. Rautlin de la, Roy YM and Grignon B. Rifampicin resistance in astrain of Brucella melitensis after treatment with doxycycline and rifampicin. J Antimicro Chemother 1986; 18: 648-649.
89. Mousa ARM, Elhag KM and Mustafa AA. The nature of human brucellosis in Kuwait. Study of 379 cases. Rev Infect Dis 1988; 10: 211.
90. Akova M and Uzun O. J Quinolones in the treatment of human brucellosis: comparative trial of oxfloxacin-rifampin versus doxycycline-rifampin. Antimicrob Chemo 1993; 37: 1831-1834.
91. Tosi MF and Nelson TJ. Brucella canis infection in a 17 -month-old child successfully treated with moxalactum. J Pediatr 1982; 101: 725-727.
92. Cespedes S, Andrews E, Floch H and Onate A. Identification and partial characterization of a new protective antigen of Brucella abortus. J Med Microbiol 2000; 49: 165.
93. Bhattaccharjee AK, Van-de-Verq L, Izadzoo MJ, Yuan L, Hadfield TL, Zollnger WD and Hoover DL. Protection of mice against brucellosis by intranasal immunization with Brucella melitensis lipopolysacchride as a noncovlant complex with Neisseria meningitides group B outer membrane protein. Infect Immun 2002; 70: 3324.
94. Mathur TN. (1968). Epidemiological studies on brucellosis. Proc. 13th Conference on Research on Animal Disease. Oct. 7-10, Madras.